NSEBSE
There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.Open1,176.2
High1,196.6
Low1,175.9
Prev. Close1,176
Avg. Traded Price1,188.91
Volume6,03,571
MARKET DEPTH
Total bid1,72,444.00
Total ask1,98,829.00
| Orders | Qty | Bid |
|---|
| 2 | 45 | 1190 |
| 3 | 674 | 1189.9 |
| 1 | 34 | 1189.8 |
| 2 | 34 | 1189.7 |
| 8 | 117 | 1189.6 |
| Ask | Qty | Orders |
|---|
| 1190.1 | 3 | 44 |
| 1190.2 | 1 | 80 |
| 1190.3 | 1 | 3 |
| 1190.4 | 2 | 30 |
| 1190.5 | 3 | 34 |
HIGH/LOW
LOW/HIGH
₹1,175.903 hours ago
₹1,196.603 hours ago
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)
ICICI Pru India Opp Fund(G)
ICICI Pru Dividend Yield Equity Fund(G)
3Y Return+22.7%
NAV₹1,361.47
Dr. Reddy’s Laboratories Limited commenced its generics business in India in 1986 and is currently a trusted name in the healthcare industry consistently serving the needs of millions of patients with high quality, affordable and innovative medicines across therapy areas. The company is a leading India-based pharmaceutical company headquartered and having its registered office in Hyderabad, Telangana, India. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the Company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and differentiated formulations.
